A-16686, a new antibiotic from actinoplanes II. Biological properties (original) (raw)
A-16686, a new antibiotic from actinoplanes II. Biological properties.:II. BIOLOGICAL PROPERTIES
Marisa Berti
The Journal of Antibiotics, 1984
View PDFchevron_right
Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2005
View PDFchevron_right
Comparison of the Antibacterial Activities of Different Antibiotics Against Clinical Isolates
sarosh malik
Pakistan BioMedical Journal, 2022
View PDFchevron_right
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovaoxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods
Ellie Hershberger
Antimicrobial Agents and Chemotherapy, 1999
View PDFchevron_right
In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Chapter e1: Anti-Infective Chemotherapeutic & Antibiotic Agents
Christian Pereira
View PDFchevron_right
Antimicrobial resistance: Action by laboratories today for a cure tomorrow
R. Kanungo
Indian Journal of Medical Microbiology, 2011
View PDFchevron_right
Bactericidal Activity of ACH-702 against Nondividing and Biofilm Staphylococci
Michael Pucci
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)
Marisa Berti
Antimicrobial Agents and Chemotherapy, 1993
View PDFchevron_right
Tolerance of staphylococcus aureus to ß-lactam antibiotics
Wil Goessens
1986
View PDFchevron_right
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus
Abhijit Chaudhury
Indian Journal of Medical Microbiology, 2007
View PDFchevron_right
Antimicrobial Activity of Actinomycetes Against Multidrug Resistant Staphylococcus aureus, E. coli and Various Other Pathogens
Tarandeep kaur
Tropical Journal of …, 2011
View PDFchevron_right
In vitro activity of BRL 36650, a new penicillin
Johan Boelaert
Antimicrobial Agents and Chemotherapy, 1986
View PDFchevron_right
The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions
David Lloyd
Journal of Applied Microbiology, 2002
View PDFchevron_right
Research Article Antimicrobial Activity of Actinomycetes Against Multidrug Resistant Staphylococcus aureus, E. coli and Various Other Pathogens
Talwinder Kaur
2011
View PDFchevron_right
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria
Donna Mildvan
Journal of Antimicrobial Chemotherapy, 1997
View PDFchevron_right
EVALUATION OF ANTIMICROBIAL ACTIVITY OF COMMERCIAL ANTIBIOTICS AGAINST SELECTIVE CLINICAL ISOLATES
BALASUBRAMANIAN SATHYAMURTHY
European Journal of Pharmaceutical and Medical Research, 2016
View PDFchevron_right
In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives
Claudia Carrilho, Inneke Marie van der Heijden, Anna Levin
Journal of Infection and Chemotherapy, 2015
View PDFchevron_right
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001)
Ronald Jones
International Journal of Antimicrobial Agents, 2003
View PDFchevron_right
COMPARATIVE ANTIBACTERIAL STRENGTH ANALYSIS OF THREE COMMONLY USED ANTIBIOTICS IN AUCHI
Emmanuel J Oboh
World Journal of Pharmaceutical Research, 2020
View PDFchevron_right
Medium-Dependent Variation in Bactericidal Activity of Antibiotics Against Susceptible Staphylococcus aureus
Dale Gerding
Antimicrobial Agents and Chemotherapy, 1978
View PDFchevron_right
Introduction to Antibiotic Therapy II - Lill - 2004
Riyad Banayot
Introduction to Antibiotic Therapy II - Lill - 2004, 2004
View PDFchevron_right
Annals of Clinical Microbiology and Antimicrobials
Hosam Zaghloul
Annals of Clinical …, 2009
View PDFchevron_right
Microbiology and drug resistance mechanisms of fullyAbbreviations MIC minimum inhibitory concentration MRSA methicillin-resistant Staphylococcus aureus
Fiona Walsh
View PDFchevron_right
Killing kinetics of vancomycin and rifampin tested alone and in combination against penicillin-resistantStreptococcus pneumoniae
Vanda Barakett
European Journal of Clinical Microbiology & Infectious Diseases, 1993
View PDFchevron_right
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic
Saroj Shah
International Journal of Antimicrobial Agents, 1998
View PDFchevron_right
PRODUCTION OF ANTIBIOTIC SUBSTANCES BY ACTINOMYCETES
Ahsanatun Syahidawati
View PDFchevron_right
MICs of Mutacin B-Ny266, Nisin A, Vancomycin, and Oxacillin against Bacterial Pathogens
Gisele LaPointe
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
New antimicrobial agents as therapy for resistant gram-positive cocci
Victor Yu
European Journal of Clinical Microbiology & Infectious Diseases, 2007
View PDFchevron_right
Antibiotic susceptibility of bacterial colonies: An assay and experiments with Staphylococcus aureus
Bruce Levin
2016
View PDFchevron_right
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria
Inga Odenholt
Clinical Microbiology and Infection, 1997
View PDFchevron_right
New antimicrobial agents for the treatment of Gram-positive bacterial infections
Serhat Unal
Clinical Microbiology and Infection, 2008
View PDFchevron_right
Journal of Advanced Scientific Research SCREENING OF ACTINOMYCETES WITH ACTIVITY AGAINST CLINICAL ISOLATES OF GRAM POSITIVE COCCI WITH MULTIRESISTANT PROFILE
Sueli Van Der Sand
View PDFchevron_right
Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right